Showing results (151-160 of 281) with videos related to
Sort By:
Pageof 29
Molecular Oncology|February 10, 2015
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast cancerMohamad Elbaz, Mohd W Nasser, Janani Ravi, et al.JAMA Network Open|July 7, 2022
Association of Allostatic Load With Overall Mortality Among Patients With Metastatic Non-Small Cell Lung CancerSamilia Obeng-Gyasi, Yaming Li, William E Carson, et al.Psycho-Oncology|October 19, 2018
Pilot randomized controlled trial of a symptom cluster intervention in advanced cancerSharla M Wells-Di Gregorio, Donald R Marks, Joseph DeCola, et al.Psychoneuroendocrinology|September 18, 2020
Within-person changes in cancer-related distress predict breast cancer survivors' inflammation across treatmentMegan E Renna, M Rosie Shrout, Annelise A Madison, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661Gini F Fleming, Neal J Meropol, Gary L Rosner, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
A phase I study of interleukin 12 with trastuzumab in patients with human epidermal growth factor receptor-2-overexpressing malignancies: analysis of sustained interferon gamma production in a subset of patientsRobin Parihar, Padma Nadella, Adrian Lewis, et al.Blood|March 18, 2006
FcgammaR-induced production of superoxide and inflammatory cytokines is differentially regulated by SHIP through its influence on PI3K and/or Ras/Erk pathwaysLatha P Ganesan, Trupti Joshi, Huiqing Fang, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 21, 2025
The association between allostatic load and lymphedema in breast cancer survivorsBarnabas Obeng-Gyasi, Yevgeniya Gokun, Mohamed I Elsaid, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Phase I study of the sequential combination of interleukin-12 and interferon alfa-2b in advanced cancer: evidence for modulation of interferon signaling pathways by interleukin-12Charles F Eisenbeis, Gregory B Lesinski, Mirela Anghelina, et al.Veterinary Immunology and Immunopathology|April 4, 2013
Ex vivo expansion of canine cytotoxic large granular lymphocytes exhibiting characteristics of natural killer cellsDong-Jun Shin, Ji-Yun Park, Youn-Young Jang, et al.Pageof 29